Antigenic imprinting in SARS-CoV-2

Clin Transl Med. 2022 Jul;12(7):e923. doi: 10.1002/ctm2.923.

S Momsen Reincke^{1

2}, Harald Prüss^{1

2}, Ian A Wilson^{3

4}, Jakob Kreye^{1

2

5}

¹ German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
² Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
³ Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
⁴ The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, USA.
⁵ Department of Pediatric Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

No abstract available

Keywords: SARS-CoV-2; antigenic imprinting; vaccination strategies; variants of concern.

MeSH terms